SEC Info - Reata Pharmaceuticals Inc. - ‘8-K’ for 4/15/21

SEC Info℠

Home

Help

Please Sign In

Reata Pharmaceuticals Inc. – ‘8-K’ for 4/15/21 – ‘XML’

On: Thursday, 4/15/21, at 6:50am ET · For: 4/15/21 · Accession #: 1564590-21-18897 · File #: 1-37785

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/21  Reata Pharmaceuticals Inc.        8-K:5,7,9   4/15/21   13:547K                                   ActiveDisclosure/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     42K 
 2: EX-10.1     Material Contract                                   HTML     92K 
 3: EX-10.2     Material Contract                                   HTML     92K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     17K 
 9: R1          Document and Entity Information                     HTML     46K 
11: XML         IDEA XML File -- Filing Summary                      XML     12K 
 8: XML         XBRL Instance -- reta-8k_20210415_htm                XML     15K 
10: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 6: EX-101.LAB  XBRL Labels -- reta-20210415_lab                     XML     56K 
 7: EX-101.PRE  XBRL Presentations -- reta-20210415_pre              XML     34K 
 5: EX-101.SCH  XBRL Schema -- reta-20210415                         XSD     19K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
13: ZIP         XBRL Zipped Folder -- 0001564590-21-018897-xbrl      Zip     59K

‘XML’ — XBRL Instance — reta-8k_20210415_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="reta-20210415.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

<dei:AmendmentFlag contextRef="C_0001358762_20210415_20210415" id="F_000001"> false </dei:AmendmentFlag>

<dei:EntityCentralIndexKey contextRef="C_0001358762_20210415_20210415" id="F_000004"> 0001358762 </dei:EntityCentralIndexKey>

<dei:DocumentType contextRef="C_0001358762_20210415_20210415" id="F_000000"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="C_0001358762_20210415_20210415" id="F_000002"> 2021-04-15 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="C_0001358762_20210415_20210415" id="F_000003"> Reata Pharmaceuticals, Inc. </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="C_0001358762_20210415_20210415" id="F_000007"> DE </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="C_0001358762_20210415_20210415" id="F_000006"> 001-37785 </dei:EntityFileNumber>

<dei:EntityTaxIdentificationNumber contextRef="C_0001358762_20210415_20210415" id="F_000008"> 11-3651945 </dei:EntityTaxIdentificationNumber>

<dei:EntityAddressAddressLine1 contextRef="C_0001358762_20210415_20210415" id="F_000009"> 5320 Legacy Drive </dei:EntityAddressAddressLine1>

<dei:EntityAddressCityOrTown contextRef="C_0001358762_20210415_20210415" id="F_000010"> Plano </dei:EntityAddressCityOrTown>

<dei:EntityAddressStateOrProvince contextRef="C_0001358762_20210415_20210415" id="F_000011"> TX </dei:EntityAddressStateOrProvince>

<dei:EntityAddressPostalZipCode contextRef="C_0001358762_20210415_20210415" id="F_000012"> 75024 </dei:EntityAddressPostalZipCode>

<dei:CityAreaCode contextRef="C_0001358762_20210415_20210415" id="F_000013"> 972 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="C_0001358762_20210415_20210415" id="F_000014"> 865-2219 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="C_0001358762_20210415_20210415" id="F_000015"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="C_0001358762_20210415_20210415" id="F_000016"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="C_0001358762_20210415_20210415" id="F_000017"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="C_0001358762_20210415_20210415" id="F_000018"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="C_0001358762_20210415_20210415" id="F_000019"> Class A Common Stock, Par Value $0.001 Per Share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="C_0001358762_20210415_20210415" id="F_000020"> RETA </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="C_0001358762_20210415_20210415" id="F_000021"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="C_0001358762_20210415_20210415" id="F_000005"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/24/23  Reata Pharmaceuticals Inc.        10-K       12/31/22   78:13M                                    Donnelley … Solutions/FA
 2/28/22  Reata Pharmaceuticals Inc.        10-K       12/31/21   93:19M                                    ActiveDisclosure/FA
11/08/21  Reata Pharmaceuticals Inc.        S-3ASR     11/08/21    3:341K                                   Donnelley … Solutions/FA
 5/06/21  Reata Pharmaceuticals Inc.        10-Q        3/31/21   58:4.7M                                   ActiveDisclosure/FA

↑Top